-+ 0.00%
-+ 0.00%
-+ 0.00%

Cumberland Pharmaceuticals Announced Results From Its Phase 2 FIGHT DMD Clinical Trial Were Selected For Late-breaking Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference In Dallas

Benzinga·03/19/2025 20:07:34
Listen to the news

Ifetroban demonstrated significant 5.4% improvement in cardiac function